Major Update for TRICARE Prime Enrollees in the West Region
January 26, 2025 - 05:21
Attention TRICARE Prime enrollees! A significant change has been announced regarding the referral process for outpatient specialty care in the West region. The Defense Health Agency has waived the requirement for pre-authorization, which means that TRICARE-authorized specialty care providers can now offer services without waiting for approval from TriWest for referrals issued by your primary care manager.
This adjustment aims to streamline access to necessary medical care, allowing patients to receive timely treatment. However, it is important to note that enrollees must still obtain a referral from their Primary Care Manager before seeking specialty care. This new process is effective retroactively from January 1, 2025, and will remain in place until March 31.
This waiver is expected to enhance the overall healthcare experience for TRICARE Prime enrollees by reducing delays in receiving specialized medical attention. Stay informed and ensure you follow the necessary steps to access your care.
MORE NEWS
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...